Search research articles
Contact Us
Filters
Showing results (461-470 of 524) with videos related to
Page
of 53
Sort By:
JAMA
|
June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancer
Jiehui Deng, David H Peng, David Fenyo, et al.
Nature Medicine
|
October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Cancer Discovery
|
July 16, 2021
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab
Prasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, et al.
Cancer Cell
|
July 19, 2024
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Cancer Cell
|
April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinoma
Harry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Journal of Hematology & Oncology
|
October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2019
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium
B T Li, F Janku, B Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Hira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Page
of 53
Search research articles
Search
Showing results (461-470 of 524) with videos related to
Sort By:
Page
of 53
JAMA
|
June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial
Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancer
Jiehui Deng, David H Peng, David Fenyo, et al.
Nature Medicine
|
October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Cancer Discovery
|
July 16, 2021
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab
Prasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, et al.
Cancer Cell
|
July 19, 2024
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Himisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Cancer Cell
|
April 21, 2023
Genomic mapping of metastatic organotropism in lung adenocarcinoma
Harry B Lengel, Brooke Mastrogiacomo, James G Connolly, et al.
Journal of Hematology & Oncology
|
October 17, 2021
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2019
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium
B T Li, F Janku, B Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Hira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.
Page
of 53